American researchers asked a group of patients to rank over a dozen injuries and conditions on a 0 to 10 pain scale, creating ...

The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other ...

Acupuncture is proving effective for chronic sciatica relief A new clinical trial reveals its potential to reduce pain and ...

According to published results, a novel opioid-free pathway may provide noninferior pain management compared with an opioid-containing pathway during the perioperative period in patients undergoing ...

The drug, Journavx, or suzetrigine, was approved to treat moderate to severe acute, or short-term, pain in adults. Experts ...

A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Andrew Dulak, a doctor of physical therapy from the University of Pittsburgh and one of Golf Digest's Best Fitness Trainers in America, is going to attempt to put you on a path to better back health ...

In summary, the present study unveiled a probable mechanism by which metformin may suppress autophagy in the sciatic nerve via an AMPK-dependent pathway that phosphorylates ... Bioenergetics, and Pain ...

A first-year B.Tech student from Kurukshetra complains of severe back pain for months. Both of them have now been diagnosed as suffering from sciatica, a pain that originates in the sciatic nerve, the ...

Semnur’s product candidate, SP-102 (SEMDEXA™), is the first non-opioid novel gel formulation administered epidurally in development for patients with moderate to severe chronic radicular pain/sciatica ...